| Lung Cancer |
1 |
1 |
| Small Cell Lung Cancer |
0 |
0.88 |
| Biologic Therapy |
0 |
0.79 |
| Antineoplastic Drug |
0 |
0.71 |
| Cancer |
0 |
0.68 |
| Lung |
0 |
0.61 |
| Healthcare and Medical Technology |
0 |
0.23 |
| Humanized Monoclonal Antibody |
0 |
0.23 |
| Drug Development |
0 |
0.15 |
| Tyrosine Kinase Inhibitor |
0 |
0.11 |
| Adverse Effects |
0 |
0.08 |
| Cardiovascular Imaging |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Diarrhea |
0 |
0.08 |
| Echocardiography |
0 |
0.08 |
| Maryland |
0 |
0.08 |
| Patient Safety |
0 |
0.08 |
| Tyrosine Kinase |
0 |
0.08 |